Fact Sheet on Fallout Report and Related Maps We offer the following observations and interpretations on the report by the Centers for Disease Control and Prevention and the National Cancer Institute, titled Progress Report to Congress: A Feasibility Study of the Health Consequences to the American Population of Nuclear Weapons Test Conducted by the United States and Other Nations (referred to hereafter as the CDC/NCI study), and its accompanying maps. These documents can be found on IEER's web site . (The report and maps are also scheduled to be posted at the Centers for Disease Control and Prevention's web site, www.cdc.gov.) The report defined the term "global fallout" as all fallout except that of tests conducted at the Nevada Test Site (NTS). "Global fallout" is thus fallout from nuclear tests conducted by Britain (at Christmas Island), the Soviet Union (at Semipalatinsk and Novaya Zemlya), and the United States (at Marshall Islands and Johnston Atoll). Cesium-137 (Cs-137) deposition is a good proxy for external gamma dose distribution on a relative basis. Therefore, Cs-137 deposition is a good proxy for distribution of the excess cancers due to external radiation. The two Cs-137 deposition maps show that most of the Cs-137 deposition in the United States was due to global (non-NTS) fallout. Hence, most of the estimated 11,000 cancer fatalities in the United States due to external gamma radiation would be due to tests conducted outside of the continental United States. States containing counties with the highest Cs-137 deposition include: Arkansas California Idaho Indiana Iowa Missouri New Hampshire North Carolina Oregon Pennsylvania South Dakota Tennessee Utah Vermont Washington Wyoming Counties in other states throughout the eastern half of the United States received substantial Cs-137 deposition. A larger number of states have counties that received substantial thyroid doses of radioactive iodine from NTS tests. The CDC/NCI study included tests conducted between 1951 and 1962. This means that: Chinese tests were not included (1964 to 1980) French atmospheric tests after 1962 were not included. Hence all French atmospheric tests in the Pacific were not included. (France conducted atmospheric tests from 1960 until 1974.) The pre-1951 tests in the Marshall Islands and the Soviet Union, the 1945 New Mexico test, and the Hiroshima and Nagasaki bombings were not included. Ventings from underground tests in the United States or the Soviet Union were not included. Calculations for Alaska and Hawaii have not been done. Alaska may have had quite a bit of fallout from Novaya Zemlya. Hawaii may have had fallout from the Marshall Islands tests. These two states need to be included in future work. They were not included because of the limitations of this feasibility stage of the study. These two states would involve different sets of data. Fallout would also be expected in other places, for instance Canada. The two bone marrow dose maps show internal plus external dose. The table in the summary of the report shows average dose weighted over the country's population. Some high fallout areas, such as many of those in the West, had a relatively low population. Therefore, even though doses to the people living in these areas were relatively high, the role of these doses in a population-weighted average would be relatively small. So it is important to be careful in relating the numbers in the table to the dose and deposition data in the maps. The table below shows estimates of occurrence and fatalities for various types of cancers as a result of nuclear testing fallout. Estimates of Cancer Occurrence and Cancer Fatalities in the United States from Global Atmospheric Nuclear Testing 48 contiguous states only Based on cumulative exposures between 1951and 2000 Does not account for all nuclear tests (see above) Type of cancer Dose type Deaths Occurrence Source Thyroid Internal ~2,500 (see note a) 50,000 (see note b) IEER estimate from NCI 1997 Leukemia Internal 550 ~1,000 CDC/NCI 2001 for deaths estimate, IEER for occurrence estimate All radiogenic cancers External 11,000 22,000 CDC/NCI 2001 All radiogenic cancers Internal Effective Dose Equivalent (see note c) ~3,000 ~6,000 IEER estimate from CDC/NCI 2001 maps and table Total, rounded (see note d)   ~17,000 ~80,000   Notes: a. Estimated by IEER by assuming a 5% mortality rate from thyroid cancer. b. Rounded best estimate of 11,000-212,000 estimated range, obtained by taking geometric mean. c. From radionuclides such as carbon-14, tritium, cesium-137. d. Rounded to one or two significant figures as indicated. Full sources referenced are: NCI 1997: National Cancer Institute, Estimate Exposures and Thyroid Doses Received by the American People from Iodine-131 from Nevada Nuclear-Bomb Tests. (Bethesda, Maryland: NCI), 1997. Online at http://rex.nci.nih.gov/INTRFCE_GIFS/radiation_fallout/radiation_131.html. CDC/NCI 2002: Progress Report to Congress: A Feasibility Study of the Health Consequences to the American Population of Nuclear Weapons Test Conducted by the United States and Other Nations, prepared by the Centers for Disease Control and Prevention and the National Cancer Institute, August 2001. (Obtained by IEER in February 2002.) Report and accompanying maps on IEER's web site.